A Usability Study of a Tele-health Service for Patients With Peripheral Arterial Disease.
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of the study is to analyze the applicability (usability) of a tele-health service as part of a potential disease management program for patients with peripheral arterial disease. The following investigations will be conducted as part of the usability study. In the context of a tele-health service, knowledge, physical condition (including walking distance) will be documented during face-to-face and televisits, dislocated supervised gait training and education will be provided, and satisfaction with the tele-health service will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2022
CompletedStudy Start
First participant enrolled
November 11, 2022
CompletedFirst Posted
Study publicly available on registry
November 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedNovember 1, 2023
October 1, 2023
10 months
May 7, 2022
October 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient satisfaction with the telehealth service.
Study participants will undergo guided interviews measuring patient satisfaction with telehealth service.
At time point visit 3, which is 12 weeks after baseline
Secondary Outcomes (8)
Proportion of patients, who would be satisfied with the telehealth service if telephone calls would not be provided by a nurse during the programme
At time point visit 3, which is 12 weeks after baseline
Change of walking distances in the 6 minute walk test determined by the certified nursing staff in response to the telehealth service.
From baseline to visit 3, which is 12 weeks after baseline
Change of subjective limitations in the activities of daily living.
From baseline to visit 3, which is 12 weeks after baseline
Change of knowledge about peripheral arterial disease.
From baseline to visit 3, which is 12 weeks after baseline
Total number of performed 6 minute walk tests during the telehealth service.
At time point visit 3, which is 12 weeks after baseline
- +3 more secondary outcomes
Eligibility Criteria
Patients diagnosed with IIa and IIb PAD at the Department of Angiology at the LKH-University Hospital Graz.
You may qualify if:
- Documented diagnosis of "peripheral arterial occlusive disease" in, IIa and IIb (according to Fontaine).
- Age between 18 and 80 years
- Written informed consent
- Smartphone with Android operating system
- Understanding of how to use the tele-health service
You may not qualify if:
- Patients with PAD stages I, III and IV (according to Fontaine)
- Lack of compliance
- Smartphone with non-Android operating system or incompatible software
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Graz
Graz, Styria, 8036, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.-Prof. Priv.-Doz. Dr.med.univ. et scient.med.
Study Record Dates
First Submitted
May 7, 2022
First Posted
November 17, 2022
Study Start
November 11, 2022
Primary Completion
August 30, 2023
Study Completion
August 30, 2023
Last Updated
November 1, 2023
Record last verified: 2023-10